Home > Animal Health & Nutrition > Veterinary Medical Devices > Johnes Disease Diagnostics Market
The global Johne’s disease diagnostics market size was valued at USD 645.6 million in 2023 and is poised to grow at 5.2% CAGR from 2024 to 2032. The market is experiencing significant growth, driven by increasing awareness about the disease and its impact on livestock health and productivity.
Johne’s disease, caused by Mycobacterium avium subspecies paratuberculosis (MAP), is a chronic gastrointestinal infection primarily affecting cattle, sheep, and goats. As more livestock producers recognize the financial implications of infected animals, the demand for effective animal diagnostics has surged.
Recent data from the USDA's National Animal Health Monitoring System (NAHMS) indicates that Johne's disease affects approximately 68% of U.S. dairy herds, with economic losses estimated at USD 200 to 250 million annually. In Europe, a 2022 study published in the Journal of Dairy Science reported prevalence rates ranging from 20% to 50% in various countries. These statistics underscore the growing need for advanced diagnostic solutions in the global livestock industry.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Johnes Disease Diagnostics Market Size in 2023: | USD 645.6 Million |
Forecast Period: | 2024 – 2032 |
Forecast Period 2024 – 2032 CAGR: | 5.2% |
2024 – 2032 Value Projection: | USD 1 Billion |
Historical Data for: | 2021 – 2023 |
No. of Pages: | 135 |
Tables, Charts & Figures: | 88 |
Segments covered: | Test Type, Animal Type, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
Furthermore, advancements in diagnostic technologies, including PCR and serological tests, have enhanced the accuracy and speed of diagnosis. These improvements make diagnostic methods more attractive to veterinarians and livestock producers. Additionally, the increasing focus on animal welfare and sustainable farming practices has prompted producers to adopt reliable diagnostic techniques for identifying and managing infected animals. As a result, these factors collectively contribute to the expansion of the Johne’s disease diagnostics market.
Johne's disease diagnostics employ multiple techniques to identify MAP, including Enzyme-Linked Immunosorbent Assay (ELISA) for antibody detection and Polymerase Chain Reaction (PCR) to identify MAP DNA in fecal samples. Timely and precise diagnosis is crucial for managing disease transmission and reducing economic impacts on livestock industries.